Gong Xiaoying, Zheng Canjie, Fang Quanjun, Xu Wenjie, Yin Zhiying
Department of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
Open Forum Infect Dis. 2024 Oct 5;11(10):ofae589. doi: 10.1093/ofid/ofae589. eCollection 2024 Oct.
Implementing hepatitis B vaccination is an important strategy to reduce hepatitis B virus infection and disease burden. Suboptimal adult hepatitis B vaccination coverage limits the further reduction of hepatitis B virus infection.
A multistage stratified random sampling method was adopted to survey the permanent population aged 1-59 in 2006 and 2024. We calculated the vaccination coverage rate, hepatitis B surface antibody (HBsAb)-positive rate, rate difference, and their 95% confidence intervals (CIs) of the 2 survey populations, and used the 95% CI and χ test to determine whether the difference in rate was statistically significant.
Six hundred twenty-three people were surveyed in 2006 and 606 people were surveyed in 2024. From 2006 to 2024, the hepatitis B vaccination coverage among people aged 1-59 years increased from 54.1% to 78.9%, and the HBsAb-positive rate increased from 46.2% to 57.6%. There was no significant difference in vaccination coverage in the population <15 years of age, but the antibody-positive rate increased significantly. The vaccination coverage rate of the 15-59 age group increased significantly, but there was no statistical difference in the antibody positivity rate of the 15-49 age group, and the antibody positivity rate of the 50-59 age group increased significantly.
Hepatitis B vaccination coverage among adults was still insufficient. Hepatitis B vaccine-mediated immunity was low in adults aged 30-49 years. It is recommended to update the guidelines for hepatitis B vaccination of adults in China, cancel the assessment of risk factors and prevaccination serological screening, and emphasize universal vaccination of all unvaccinated adults to increase coverage.
实施乙肝疫苗接种是降低乙肝病毒感染和疾病负担的重要策略。成人乙肝疫苗接种覆盖率不理想限制了乙肝病毒感染的进一步降低。
采用多阶段分层随机抽样方法,对2006年和2024年1至59岁常住人口进行调查。计算两个调查人群的疫苗接种覆盖率、乙肝表面抗体(HBsAb)阳性率、率差及其95%置信区间(CIs),并使用95%CI和χ检验确定率的差异是否具有统计学意义。
2006年调查623人,2024年调查606人。2006年至2024年,1至59岁人群的乙肝疫苗接种覆盖率从54.1%提高到78.9%,HBsAb阳性率从46.2%提高到57.6%。15岁以下人群的疫苗接种覆盖率无显著差异,但抗体阳性率显著提高。15至59岁年龄组的疫苗接种覆盖率显著提高,但15至49岁年龄组的抗体阳性率无统计学差异,50至59岁年龄组的抗体阳性率显著提高。
成人乙肝疫苗接种覆盖率仍不足。30至49岁成年人中乙肝疫苗介导的免疫力较低。建议更新我国成人乙肝疫苗接种指南,取消危险因素评估和接种前血清学筛查,强调对所有未接种的成年人进行普遍接种以提高覆盖率。